prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype LumA, Breast, left, wide-local excision: Invasive ductal adenocarcinoma, Nottingham grade III (of III), forming. a mass 2.3 x 2.0 x 2.0 cm (AJCC pT2). Ductal carcinoma in-situ, high nuclear grade, solid type. comprises 10% of the tumor. The surgical margins are negative for tumor. Lymph nodes, left axillary sentinel, excision: A single (1) left axillary sentinel lymph node is positive for. tumor (AJCC pN1mi). No blue dye identified. Lymph nodes, left axillary, excision: Multiple (3) left axillary lymph nodes are negative for tumor. (AJCC pNO). Estrogen: Positive, > 10% nuclear staining. Progesterone: Focally Positive, 1-10% nuclear staining. ER (Estrogen Receptor) test was developed and its performance characteristics determined by. It has not been cleared or approved by the U.S. Food. and Drug Administration.

expanded version (tokens=632) : 
 Here are the extracted information from the breast pathology report:

1. Histological classification: Invasive ductal adenocarcinoma and ductal carcinoma in-situ (high nuclear grade, solid type)
2. Subtype: LumA
3. Size: Forming a mass 2.3 x 2.0 x 2.0 cm (AJCC pT2)
4. Nottingham grade: III (of III)
5. Necrosis: No mention of necrosis
6. Tumor infiltrating lymphocytes: No mention of tumor-infiltrating lymphocytes
7. Histological grade: Nottingham grade III (of III)
8. Nuclear grade: High nuclear grade in the ductal carcinoma in-situ component
9. Lymphovascular invasion: No mention of lymphovascular invasion
10. Calcification: No mention of calcification
11. Receptor status: 
  a. Estrogen receptor (ER): Positive, > 10% nuclear staining
  b. Progesterone receptor (PR): Focally positive, 1-10% nuclear staining
12. IHC and other ancillary testing results:
  a. ER test was developed and its performance characteristics determined
  b. The test has not been cleared or approved by the US FDA.

Overall, the report indicates that there is evidence of invasive and in-situ ductal carcinoma with a high histological grade of III. The tumor is positive for estrogen receptor

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=787) : 
 Report: LumA subtype breast tumor consisting of invasive ductal adenocarcinoma (2.3 x 2.0 x 2.0cm, Nottingham grade III) and high nuclear grade ductal carcinoma in-situ (10% of tumor). Negative surgical margins. One left axillary sentinel lymph node positive for tumor (pN1mi); three negative (pNO). ER-positive (>10% nuclear staining); PR focally positive (1-10% nuclear staining). No other notable features or findings reported.

